GLA
AVXL icon

Great Lakes Advisors’s Anavex Life Sciences AVXL Stock Holding History

Great Lakes Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-679,703
Closed -$15.5M – 696
2021
Q2 		$15.5M Sell
679,703
-9,189
-1% -$136K 0.23% 137
2021
Q1 		$10.3M Buy
+688,892
New +$7.52M 0.17% 184

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Great Lakes Advisors's AVXL Position: Q3 2021 in Review

Great Lakes Advisors sold out of Anavex Life Sciences (AVXL) in Q3 2021, closing a stake of 679,703 shares — an estimated $15.5M sold.

Great Lakes Advisors first reported a position in AVXL in Q1 2021 and held it in 2 quarters. The position peaked at $15.5M in Q2 2021. 136 funds tracked by Wall St. Rank hold AVXL as of Q3 2021.

  • Great Lakes Advisors reported no remaining Anavex Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Great Lakes Advisors sold 679,703 Anavex Life Sciences shares in Q3 2021, an estimated $15.5M.
  • Great Lakes Advisors first reported a position in Anavex Life Sciences in Q1 2021 and held it in 2 quarters.
  • Great Lakes Advisors's Anavex Life Sciences position peaked at $15.5M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2021.

Based on Great Lakes Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.